Relmada Therapeutics RLMD
NASDAQ RLMD
$4.27 +0.13 (+3.14%)
At close: Nov 10, 2026 · 4:00 PM EST

Relmada Therapeutics (RLMD) Other financing activities (as filed) (2024 - 2026)

Updated

Relmada Therapeutics (RLMD) recorded Other financing activities (as filed) of -$66,273 in Q2 2026.

Analysis

Relmada Therapeutics (RLMD) Other financing activities (as filed) (2024 - 2026) Analysis & Trends

On a TTM basis, Relmada Therapeutics' Other financing activities (as filed) came in at -$131,924 as of Jun 30, 2026; for FY2025, it was -$73,021.

  • Across earlier years, Other financing activities (as filed) came in at -$287,088 in FY2024 and -$98,463 in FY2023.
  • The Q2 2026 figure is the lowest quarterly Other financing activities (as filed) since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Relmada Therapeutics 473.10 Mn -85.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -66,273.00
Mar 31, 2026 -65,651.00
Dec 31, 2024 -172,487.00
Sep 30, 2024 -89,601.00
Mar 31, 2024 -25,000.00
API Access

Relmada Therapeutics Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=RLMD&period=max&api_key=YOUR_API_KEY